Improving Outcomes in Heart Failure – Focus on Guideline Adherence and Comorbidities
Published: 29 September 2020
-
Views:
265
-
Likes:
7
-
Views:
265
-
Likes:
7
Overview
In this series from the e-SPACE Heart Failure Global Web-Conference, Ileana Piña, Peter van der Meer and Stefan Anker discuss improving outcomes in heart failure with a focus on guideline adherence and comorbidities.
Educational objectives
- Review Pharmacological Treatments That Reduce Mortality and Hospitalisations in Patients With Heart Failure
- Evaluate Adherence to Heart Failure Management Guidelines and Barriers to Optimal Use of Guideline-Recommended Therapy
- Recognise the Importance of Integrated Care of Comorbidities in the Management of Heart Failure Patients
- Assess the Role of Novel Potassium Binders in Optimising Optimal Renin–Angiotensin– Aldosterone System Inhibitor (RAASi) Therapy in Patients With Heart Failure
- Review the Benefits of Treating Iron Deficiency in Heart Failure With Respect to Functional Capacity and Symptomatic Improvement
Symposium Agenda
- Time - Session title and Objective - Speaker(s)
- 20 mins - Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization - Ileana L. Piña, Detroit, MI, USA
- 20 mins - Optimising RAASi Therapy Through Long-Term Potassium Control - Javed Butler, Atlanta, GA, USA
- 20 mins - Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life - Peter van der Meer, Groningen, The Netherlands
- 25 mins - Interactive Panel Discussion - Stefan Anker & Javed Butler
More from this programme
Part 1
Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization
Part 2
Optimising RAASi Therapy Through Long-Term Potassium Control
Part 3
Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life
Part 4
Panel Discussion
| 1 session | |
| Panel Discussion | Watch now |
Faculty Biographies
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.